Variation in age at cancer diagnosis in familial versus nonfamilial Barrett's esophagus.
Amitabh Chak, Yanwen Chen, Jaime Vengoechea...
https://pubmed.ncbi.nlm.nih.gov/22178570/Actively Recruiting
Led by Case Western Reserve University · Updated on 2026-08-10
2000
Participants Needed
10
Research Sites
N/A
Total Duration
Researchers are conducting a comprehensive study to understand the genetic and environmental factors involved in Barretts esophagus BE and esophageal adenocarcinoma EAC. The study aims to improve biological understanding and develop better methods for detection, prognosis, prevention, and treatment of these conditions. This research center builds on existing collaborations and expertise to translate laboratory discoveries into clinical applications that can help prevent EAC and enhance patient outcomes. Participants will undergo esophageal sampling using a non-endoscopic balloon capsule device, which is swallowed and inflated to collect tissue samples from the esophagus. The collected samples are preserved for genetic and molecular analysis. Additionally, all participants will have a standard upper endoscopy EGD, with biopsies taken from targeted areas based on imaging techniques. Cases and controls will also have research brushings and biopsies from different parts of the esophagus and stomach to support comprehensive research. During the study, participants may be asked about their experience with the non-endoscopic sampling, including discomfort levels compared to the standard endoscopy. Researchers will analyze DNA and RNA markers from the collected samples within one week and evaluate the tolerability of the procedures shortly after. The study involves long-term monitoring and aims to improve the understanding and early detection of BE and EAC, with participation lasting until the study completion date in 2028.
CONDITIONS
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
A
Amitabh Chak, MD
W
Wendy Brock, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Case Western Reserve University
Lead Sponsor
University Hospitals Cleveland Medical Center
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Varies by participant
Participants swallow a balloon capsule device to collect esophageal tissue samples and undergo a standard upper endoscopy with biopsies from targeted areas. Additional research brushings and biopsies are taken for genetic analysis.
1 visit for capsule sampling and endoscopy
Duration - Short term after procedures
Participants provide feedback on procedure discomfort and tolerability. Researchers analyze collected DNA and RNA markers and monitor participants for any adverse events.
1 visit shortly after procedures
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Amitabh Chak, Yanwen Chen, Jaime Vengoechea...
https://pubmed.ncbi.nlm.nih.gov/22178570/Helen R Moinova, Suman Verma, John Dumot...
https://pubmed.ncbi.nlm.nih.gov/38686933/Christopher Douville, Helen R Moinova, Prashanthi N Thota...
https://pubmed.ncbi.nlm.nih.gov/33493502/Case Western Reserve University
Lead Sponsor
University Hospitals Cleveland Medical Center
Collaborating Sponsor